Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Microbiology · Poland · 2025-04-22

Processing Time
489 days
Decision Date
2025-04-22
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop synthetic antibodies with enhanced functional activity against infectious agents, specifically focusing on antibody engineering strategies for conditions like HIV. This work aims to create potent, long-acting solutions for disease prevention and treatment to lower transmission rates and healthcare burdens.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses persistent public health concerns and infectious disease transmission, supported by funding from major federal agencies like NIH and NASA.

2 Well-positioned to Advance the Endeavor Met

The petitioner's PhD, publication record in high-impact journals, and 64 citations demonstrate their scientific influence and position in the field.

3 Balance of Interests Met

The petitioner's contributions to vaccine development and therapeutics provide a clear benefit to U.S. healthcare that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles, a book chapter, and 64 citations, with two papers ranking among the most-cited in the field. Evidence included funding from NIH, NSF, and NASA, as well as participation in over 5 peer reviews for reputable journals. The case successfully satisfied all three Dhanasar prongs through expert support and demonstrated global adoption of the petitioner's methods.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 292 days 2025-02-27
The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.
View Case

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
California 30 days 2023-02-09
The petitioner proposes to continue her research on advancing novel protein characterization approaches for discovering and engineering antibodies. This work focuses on developing a protein engineering strategy to produce antibodies with improved dose potency and creating new therapeutics that target difficult diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Poland

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 489 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Poland All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist